In today's world, Fluorotabun has become a topic of great importance and interest to a wide range of people. From academics to professionals from various sectors, everyone seems to be interested in deepening their knowledge of Fluorotabun. This topic has captured the attention of society in general, generating debates, reflections and analysis about its impact and relevance in different areas. In this article, we will explore the different perspectives and approaches related to Fluorotabun, with the aim of shedding light on this important and current topic.
Names | |
---|---|
IUPAC name
Ethyl dimethylphosphoramidofluoridate
| |
Identifiers | |
3D model (JSmol)
|
|
ChemSpider | |
PubChem CID
|
|
CompTox Dashboard (EPA)
|
|
| |
| |
Properties | |
C4H11FNO2P | |
Molar mass | 155.109 g·mol−1 |
Hazards | |
Occupational safety and health (OHS/OSH): | |
Main hazards
|
Highly toxic |
Lethal dose or concentration (LD, LC): | |
LD50 (median dose)
|
2.5 mg/kg (mice, intraperitoneal) |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C , 100 kPa).
|
Fluorotabun is a highly toxic organophosphate nerve agent of the G-series. It's the fluorinated analog of tabun, i.e. the cyanide group is replaced by a fluorine atom.
GAF is considered an ineffective GA-like agent. It is less effective than GAA.